BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Souza I, Monteiro LKS, Guedes CB, Silva MM, Andrade-Tomaz M, Contieri B, Latancia MT, Mendes D, Porchia BFMM, Lazarini M, Gomes LR, Rocha CRR. High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1/MRP1 upregulation. Cell Death Dis 2022;13:591. [PMID: 35803910 DOI: 10.1038/s41419-022-05044-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Cheng H, Wang P, Wang N, Dong W, Chen Z, Wu M, Wang Z, Yu Z, Guan D, Wang L, Zhao R. Neuroprotection of NRF2 against Ferroptosis after Traumatic Brain Injury in Mice. Antioxidants 2023;12:731. [DOI: 10.3390/antiox12030731] [Reference Citation Analysis]
2 Lu Q, Lu X, Zhang Y, Huang W, Zhou H, Li T. Recent advances in ferroptosis and therapeutic strategies for glioblastoma. Front Mol Biosci 2022;9:1068437. [PMID: 36710875 DOI: 10.3389/fmolb.2022.1068437] [Reference Citation Analysis]
3 Miska J, Chandel NS. Targeting fatty acid metabolism in glioblastoma. J Clin Invest 2023;133. [PMID: 36594473 DOI: 10.1172/JCI163448] [Reference Citation Analysis]
4 Wang Y, Wu X, Ren Z, Li Y, Zou W, Chen J, Wang H. Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resist Updat 2023;66:100916. [PMID: 36610291 DOI: 10.1016/j.drup.2022.100916] [Reference Citation Analysis]
5 Chi H, Li B, Wang Q, Gao Z, Feng B, Xue H, Li G. Opportunities and challenges related to ferroptosis in glioma and neuroblastoma. Front Oncol 2023;13:1065994. [PMID: 36937406 DOI: 10.3389/fonc.2023.1065994] [Reference Citation Analysis]